Table 2

Post-randomisation distribution of risk variables and adherence according to treatment group for women with a history of premature delivery (HPD)

Placebo

Treatment

Total




Factor

Frequency

%

Mean

Frequency

%

Mean

Frequency

%

Mean




Gestacional Age at

Randomization

< 12w

2

12.5%

11w.6d

2

10.5%

11w.1d

4

11.4%

11w.4d

(12w-16w)

7

43.8%

14w.3d

7

36.8%

14w.3d

14

40.0%

14w.3d

(16w-20w)

7

43.8%

17w.5d

10

52.6%

19w.4d

17

48.6%

18w.6d

Total

16

100.0%

15w.4d

19

100.0%

16w.5d

35

100.0%

16w.2d

Nugent Score

4-6

5

31.3%

4.8

5

26.3%

5.4

10

28.6%

5.1

7-8

9

56.3%

7.8

9

47.4%

7.7

18

51.4%

7.7

9-10

2

12.5%

9.0

5

26.3%

9.0

7

20.0%

9.0

Total

16

100.0%

7

19

100.0%

7.4

35

100.0%

7.2

Height(m)

< = 1.55

4

25.0%

1.51

5

26.3%

1.53

9

25.7%

1.52

>1.55

12

75.0%

1.64

14

73.7%

1.63

26

74.3%

1.63

Total

16

100.0%

1.61

19

100.0%

1.60

35

100.0%

1.60

Ethnicity

White

3

18.8%

5

26.3%

8

22.9%

Black

13

81.2%

14

73.7%

27

77.1%

Total

16

100.0%

19

100.0%

35

100.0%

Adherence

No

4

25.0%

7

36.8%

11

31.4%

Yes

12

75.0%

12

63.2%

24

68.6%

Total

16

100.05

19

100.0%

35

100.0%


Krauss-Silva et al. Trials 2011 12:239   doi:10.1186/1745-6215-12-239

Open Data